Clinical Trial: Safety and Efficacy of ELAD to Treat Acute Liver Failure (ALF)

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: An Open-Label, Multicenter, Historically-Controlled Study to Assess Safety and Efficacy of ELAD in Subjects With Acute Liver Failure (ALF)

Brief Summary: This phase 2 study is developed to evaluate the effect of ELAD on overall survival (OS) in subjects with acute liver failure (ALF) compared to matched historical controls.